Shang, B. Comment on “Major adverse cardiac and cerebrovascular events (MACCEs) in patients with acute ST-segment elevation myocardial infarction (STEMI) treated with pharmaco-invasive strategy of half-dose recombinant human prourokinase (PHDP): Two-year outcomes”. Elsevier.
Chicago Style (17th ed.) CitationShang, Bo. Comment on “Major Adverse Cardiac and Cerebrovascular Events (MACCEs) in Patients with Acute ST-segment Elevation Myocardial Infarction (STEMI) Treated with Pharmaco-invasive Strategy of Half-dose Recombinant Human Prourokinase (PHDP): Two-year Outcomes”. Elsevier.
MLA (9th ed.) CitationShang, Bo. Comment on “Major Adverse Cardiac and Cerebrovascular Events (MACCEs) in Patients with Acute ST-segment Elevation Myocardial Infarction (STEMI) Treated with Pharmaco-invasive Strategy of Half-dose Recombinant Human Prourokinase (PHDP): Two-year Outcomes”. Elsevier.